Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-14

Clinical Trial Update: To Evaluate the Pharmacokinetics and Safety/Tolerability of Lacosamide in 3 Dosages in Healthy Male Korean Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessing pharmacokinetics and safety/tolerability of lacosamide across three doses in healthy male Korean volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 1 | Status: COMPLETED